Radico Khaitan: Premium servings

India Infoline News Service | Mumbai |

Premium brands are likely to double their share to 19.7% in next two years from just ~10% in FY10, led by ~17%/30% compounded increase over FY12-15 in the two brands.

CMP Rs134, Target Rs160, Upside 19.2%

We interacted with the management of Radico Khaitan to get an outlook for the company’s IMFL business especially the growth prognosis for premium brands. From a ~10% share of overall volumes in FY10, premium brands (Magic Moments vodka & Morpheus brandy) are likely to raise their share to 19.7% by FY15. Company expects premium brands to post 18-20% annual growth over the next 1-2 years while other main line brands like 8PM whisky are likely to post 6-7% rise in the next fiscal. However, the focus would remain on portfolio premiumization as a driver of margin and profitability given higher EBIDTA/case. Radico expects 100-150bps rise in margin over the next 3 years which in turn would support improvement in return ratios. Given the growth of premium whisky segment, we believe a portfolio of premium brands is necessary to counter sustained cost pressures and Radico’s premium focus is a step in the right direction. Retain BUY for 9-12 mth target of Rs160.  


Premium brands share to rise ~20% by FY15

Premium brands are likely to double their share to 19.7% in next two years from just ~10% in FY10, led by ~17%/30% compounded increase over FY12-15 in the two brands. Overall premium brands portfolio can record a~19% cagr in the next two years. Rest of the mainline brands like 8PM whisky and Old Admiral VSOP brandy are likely to grow at a subdued 6-7% annual pace.


Margin, RoE set to improve; valuations supportive, retain BUY

A better revenue mix and select price hikes would raise margin by ~85bps in the next two years, which in turn would support higher return ratios. We expect company to be FCF positive in the next fiscal as operating cash flow turns around. Stock trades at the lower end of its historic 1-yr fwd EV/EBIDTA range and given the scope of improvement in OPM and return ratios, we believe it deserves a higher multiple; we marginally tweak our EPS estimates but retain BUY for 9-12 month target of Rs160.   


Financial summary
Y/e 31 March  (Rs m) FY12 FY13E FY14E FY15E
Revenues 11,439 12,794 13,973 15,367
yoy growth (%) 20.9 11.9 9.2 10.0
Operating profit 1,720 2,041 2,306 2,582
OPM (%) 15.0 16.0 16.5 16.8
Pre-exceptional PAT 762 816 1,023 1,247
Reported PAT 637 816 1,023 1,247
yoy growth (%) (12.6) 28.3 25.3 21.9
         
EPS (Rs) 4.8 6.2 7.7 9.4
P/E (x) 27.9 21.8 17.4 14.2
P/BV (x) 2.6 2.3 2.1 1.8
EV/EBITDA (x) 13.8 11.8 10.5 9.3
Debt/Equity (x) 0.9 0.9 0.8 0.6
ROE (%) 11.3 11.2 12.6 13.7
ROCE (%) 12.5 13.3 14.2 15.1
Source: Company, India Infoline Research

 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.